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Abstract
Background: Malaria triggers a high inflammatory response in the host that mediates most of the associated pathologies
and contributes to death. The identification of pro-inflammatory molecules derived from Plasmodium is essential to
understand the mechanisms of pathogenesis and to develop targeted interventions. Uric acid derived from hypoxanthine
accumulated in infected erythrocytes has been recently proposed as a mediator of inflammation in rodent malaria.
Methods and Findings: We found that human erythrocytes infected with Plasmodium falciparum gradually accumulate
hypoxanthine in their late stages of development. To analyze the role of hypoxanthine-derived uric acid induced by P.
falciparum on the inflammatory cytokine response from human blood mononuclear cells, cultures were treated with
allopurinol, to inhibit uric acid formation from hypoxanthine, or with uricase, to degrade uric acid. Both treatments
significantly reduce the secretion of TNF, IL-6, IL-1b and IL-10 from human cells.
Conclusions and Significance: Uric acid is a major contributor of the inflammatory response triggered by P. falciparum in
human peripheral blood mononuclear cells. Since the inflammatory reaction induced by P. falciparum is considered a major
cause of malaria pathogenesis, identifying the mechanisms used by the parasite to induce the host inflammatory response
is essential to develop urgently needed therapies against this disease.
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Introduction
Malaria is one of the more devastating diseases in developing
countries with more than one million deaths per year, mostly in
children under the age of five [1]. The disease is caused by
infection with the Plasmodium parasite, being Plasmodium falciparum
the most deadly parasite species infecting humans. Plasmodium
replicates within erythrocytes in the blood. The rupture of infected
erythrocytes induces a strong inflammatory response in the host
that is mediated by factors derived from the parasite. Since most of
the pathologies associated with malaria are caused by the excessive
inflammatory response triggered in the host [2], identifying pro-
inflammatory molecules derived from P. falciparum is essential to
understand the mechanisms of pathogenesis and to develop
targeted interventions.
Two P. falciparum-derived molecules that induce inflammatory
responses mediated by the activation of Toll-like receptors have
been found: glycosylphosphatidylinositol (GPI) anchors [3] and a
parasite-induced polymer of degraded heme called hemozoin that
is covered with DNA from the parasite [4,5]. While these
molecules may contribute to the malaria-induced pathogenesis, it
is clear that other P. falciparum-derived inflammatory mediators
remain unknown [6]. Recently, uric acid derived from hypoxan-
thine accumulated by the parasite was described as a source of
inflammation in Plasmodium yoelii, a mouse malaria model [7].
In this work, we show for the first time that uric acid derived
from hypoxanthine accumulated by Plasmodium falciparum-infected
erythrocytes is a major contributor of the inflammatory response
triggered in human peripheral blood mononuclear cells (PBMCs).
Interestingly, a clinical trial using an inhibitor of uric acid
formation in malaria patients showed a strong reduction of the
inflammatory response [8]. Taken together with our observations,
these results suggest a major role of uric acid in the inflammatory
response to malaria.
Results
Analysis of erythrocytes infected with the rodent parasite P. yoelii,
showed that they accumulate high concentrations of hypoxanthine
and/or xanthine. Enzymatic results using P. falciparum-infected
erythrocytes suggested that theyalsoaccumulate hypoxanthine and/
or xanthine [7]. Here, we sought to specifically confirm the
accumulation of hypoxanthine in P. falciparum-infected erythrocytes
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chromatography (GC) - selected reaction monitoring mass spectros-
copy(MS) we determined that lysates ofthe moremature stages of P.
falciparum-infected erythrocytes, containing mainly schizonts and late
throphozoites, accumulate high levels of hypoxanthine (Fig. 1). This
accumulation in the late stages of development is probably the result
of a decreased requirement for hypoxanthine by the parasite after
the DNAofdaughtermerozoiteshasbeensynthesized.Accumulated
hypoxanthine is released by infected erythrocytes after rupture [7],
and is converted into uric acid by xanthine oxidoreductase, an
enzyme that is present in blood and tissues [9]. Since neither
erythrocytes nor Plasmodium, have xanthine oxidoreductase activity,
the hypoxanthine is not converted into uric acid inside the infected
erythrocytes. As expected, the levels of uric acid in lysates of P.
falciparum schizonts and late throphozoites were very low (below the
detection threshold, data not shown).
To study the role of hypoxanthine degradation in the
inflammatory response induced by P. falciparum, we analyzed the
levels of inflammatory cytokines secreted by PBMCs in response to
P. falciparum-infected erythrocytes [10]. We first performed
titration experiments in which PBMCs were incubated with
various concentrations of mature P. falciparum-infected erythrocytes
(schizonts) to establish the optimal ratios of cells. We observed a
dose dependent effect of P. falciparum infected erythrocytes on
PBMC production of the inflammatory cytokines, TNF (Fig. 2A),
IL-6 (Fig. 2B) and IL-1b (Fig. 2C).
To determine if hypoxanthine degradation plays a role in P.
falciparum induced production of inflammatory mediators, we used
allopurinol, an inhibitor of xanthine oxidoreductase that prevents
the formation of uric acid from hypoxanthine or xanthine [11].
Despite having toxic effects on other parasites, allopurinol did not
inhibit the growth of P. falciparum in vitro (Fig. 2D) or in vivo [8,12].
We incubated PBMCs with P. falciparum-infected erythrocytes in
late developmental stage (schizonts) in the presence or absence of
allopurinol to inhibit hypoxanthine degradation. We found that
the release of TNF, IL-6, IL-1b and IL-10 by PBMCs was
significantly inhibited by allopurinol (Fig. 3A–D), suggesting that
hypoxanthine degradation plays an important role in the
inflammatory response induced by P. falciparum.
To determine if hypoxanthine-derived uric acid was responsible
for the inflammatory cytokine response observed, we incubated
PBMCs with P. falciparum infected erythrocytes in the presence of
uricase, an enzyme that specifically degrades uric acid. Similar to
allopurinol, we found a significant inhibition of the TNF, IL-6, IL-
1b and IL-10 response in PBMCs (Fig. 3E–H). Taken together,
these results suggest that uric acid derived from hypoxanthine in P.
falciparum-infected erythrocytes is a major contributor of the
inflammatory cytokine response from PBMCs.
Figure 1. Mature P. falciparum infected erythrocytes accumulate high levels of hypoxanthine. Hypoxanthine was analyzed in the soluble
fraction of lysates of human erythrocytes infected with P. falciparum at different times after infection in a synchronized culture. Lysates of uninfected
erythrocytes cultured for the same times were used as controls. Shown are GC - selected reaction monitoring MS ion plots using the m/z 365.2 to m/z
251.2 product ion MS/MS transition. Hypoxanthine accumulated in cultured uninfected erythrocytes (red lines) and P. falciparum infected
erythrocytes (black lines) is shown. Infected erythrocytes at 33 h (mature trophozoites, thick lines) and 40 h (schizonts, think lines) were purified from
synchronized cultures of 2% parasitemia.
doi:10.1371/journal.pone.0005194.g001
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of PBMCs incubated with P. falciparum infected erythrocytes,
where the inflammatory reaction takes place. We found low levels
of uric acid (1.3 mM), which were similar to levels in PBMCs
incubated control erythrocytes, and significantly lower than
the crystallization threshold of uric acid in biological fluids is
(100 mg/ml) [13].
We next characterized the inflammatory cytokine response at
different times after incubation of PBMCs with P. falciparum-
infected erythrocytes. We found that TNF secretion was inhibited
at early time points, but was not greatly affected at 24 h (Fig. 4A).
These results suggest that the early TNF response is mediated by
hypoxanthine degradation into uric acid, but that additional
inflammatory parasite-derived molecules trigger the late secretion
of TNF. Similar results were found for IL-6, IL-1b and IL-10,
although the allopurinol-induced inhibition persisted at 24 h in the
case of IL-1b (Fig. 4 B–D).
Discussion
Since the host inflammatory response contributes decisively to
the pathology caused by Plasmodium infection [2], finding the
parasite mediators that trigger inflammation is essential to
design new therapeutic strategies that could interfere with the
pathological syndromes induced by the disease. Two different
parasite derived molecules, GPI [3] and hemozoin bound to
parasite DNA [4,5], induce inflammatory cytokine responses when
purified from parasite lysates. However, the contribution of each
to the inflammatory response triggered by the parasite has not
been quantified in vitro or in vivo. Here we quantified the
contribution of uric acid in the inflammatory response in vitro,
showing that uric acid is an important participant, but not the only
P. falciparum-derived pro-inflammatory molecule activating human
PBMCs.
The inflammatory properties of uric acid have been know for
decades because of gout, a disease caused by excessively high
concentrations of uric acid that crystallizes in the joints triggering
an inflammatory response [14]. Uric acid was also characterized as
a ‘danger signal’ that is released from necrotic cells and alerts the
immune system [15]. More recently it was shown that uric acid is
the cause of the adjuvant effect induced by alum [16]. Here we
show that hypoxanthine is accumulated in P. falciparum-infected
erythrocytes and that its degradation into uric acid results in the
activation of an inflammatory response from human PBMCs. Our
Figure 2. Mature P. falciparum infected erythrocytes induce TNF, IL-6 and IL-1b from PBMCs. (A–C) PBMCs were incubated with mature P.
falciparum infected erythrocytes (squares) or uninfected erythrocytes (circles) at the indicated ratio of erythrocyte to PBMC for 6 h. Data represent the
average of triplicated samples with standard deviations. Incubation media were collected and TNF (A), IL-6 (B), or IL-1b (C) concentrations were
determined by flow cytometry using cytometric bead array. (D) P. falciparum infected erythrocytes were cultivated alone or in the presence of 2 mM
allopurinol. Synchronized cultures were seeded at 0.5% rings and the culture media was changed daily. The percentage of infected erythrocytes was
calculated after 0 h (black bars), 24 h (white bars) and 48 h (grey bars) of culture.
doi:10.1371/journal.pone.0005194.g002
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throughout human history, may be added to the increasing list of
inflammatory processes where uric acid plays an essential role.
We found that uric acid contributes significantly to the secretion
of TNF, IL-1b and IL-6 by PBMCs in response to P. falciparum-
infected erythrocytes. These three cytokines are considered
indicative of inflammatory responses, elevated in malaria patients,
and associated with the severity of malaria [17–19]. TNF has
traditionally been used as a reporter to identify the ‘malarial toxin’,
a name given to the pro-inflammatory molecules derived from
Plasmodium [20]. The secretion of TNF by PBMC in response to P.
falciparum correlates with the stage of the parasite, with schizonts
inducing the highest TNF responses and ring stages not inducing
any response [10]. Interestingly, we found that the accumulation
of hypoxanthine also seems to increase with the progression of the
parasite developmental cycle.
We also found increases in IL-10, a well-characterized
regulatory cytokine [21], that are dependent on the formation of
uric acid. The release of IL-10 after 9 h of incubation is probably a
consequence of the initial inflammatory wave of inflammatory
cytokines detectable already at 3 h, since inflammatory cytokines
such as TNF induce IL-10 release from immune cells [22].
Accordingly, the reduction in IL-10 release after inhibition of the
uric acid pathway could be a consequence of the decreased early
inflammatory cytokines.
We used both allopurinol, an inhibitor of the generation of uric
acid from hypoxanthine and xanthine, and uricase, an enzyme
that catalyzes the oxidation of uric acid, to investigate the role of
uric acid in P.falciparum-induced inflammation. Uricase is a highly
conserved ancient enzyme that is found in both prokaryotes and
eukaryotes, however, hominoids have lost uricase activity [23].
The lack of an active uricase enzyme in humans is the cause of the
high levels of circulating uric acid, which predisposes humans to
crystalline deposition and gout [24]. These high levels of
circulating uric acid are increased even more during P. falciparum
infection [25] and can reach levels that are close to the
crystallization threshold in biological fluids (100 mg/ml) [13].
Renal dysfunction that is observed during severe malaria infections
probably contributes to the increased uric acid levels observed in
plasma [26], rendering patients more vulnerable to additional
increases of uric acid due to hypoxanthine degradation upon
infected erythrocytes rupture. A local increase in uric acid is likely
to occur after the rupture of infected erythrocytes, since this is a
synchronized event that is perhaps more pronounced in certain
tissues where infected erythrocytes tend to accumulate [27]. These
high local concentrations of uric acid would lead to inflammatory
responses that can be triggered by either soluble or crystallized uric
acid [28]. Interestingly, in mice treated with alum, the levels of
uric acid were significantly increased [16], but were still three
times lower than the urate threshold of crystallization, suggesting
that elevated levels of soluble uric acid may have a strong
inflammatory activity. We also find uric acid levels below the
crystallization threshold in vitro, suggesting that soluble uric acid
may be the mediator of the response observed in PBMC.
The pathways used by uric acid to trigger inflammatory
responses are not fully characterized. It is known that crystallized
uric acid induces IL-1b through the NALP3 inflammasome
pathway [29], however, the pathway used to induce TNF remains
unknown. Using mouse cells, we previously found that the
signaling pathway induced by Plasmodium is independent of
MyD88 (and likely of TLR) and it is different from the pathway
used by crystallized uric acid to trigger IL-1b [7].
Figure 3. P. falciparum-derived uric acid induces TNF, IL-6 and IL-1b release from PBMCs. PBMCs were incubated with media alone
(control), uninfected erythrocytes (RBCs) or P. falciparum-infected erythrocytes (iRBCs) at a ratio of (5:1; erythrocyte:PBMC) for 6 h (24 h for IL-10) in
the absence (black bars) or presence (white bars) of 2 mM allopurinol (A–D) or 0.1 mg/ml uricase (E–H). Incubation media were collected and TNF
(A,E), IL-6 (B,F), IL-1b (C,G) and IL-10 (D,H) concentrations were determined by flow cytometry using cytometric bead array. Data represent the
average of triplicated samples with standard deviations. *, indicates significant differences (p,0.05) in cytokine release by PBMCs incubated with
iRBCs when compared to IRBCs in the presence of allopurinol or uricase.
doi:10.1371/journal.pone.0005194.g003
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humans during malaria. When groups of acute malaria patients
infected with P. falciparum were treated with allopurinol in addition
to the anti-malarial drug quinine, a significantly faster decrease in
fever levels and splenomegaly was observed compared to the
group of patients treated only with quinine. This reduction of
inflammation was observed without a significant decrease in
parasite clearance, indicating that the anti-inflammatory effect of
allopurinol is mediated by the specific inhibition of an inflamma-
tory pathway and not by a direct effect on the parasite. These
results suggest that the hypoxanthine degradation pathway plays
an important role in the human inflammatory response to malaria
[8].
We have identified P. falciparum-derived uric acid as a parasite
mediator that triggers inflammation. While treatments to interfere
with inflammation-induced pathologies are essential, therapies to
reduce the levels of uric acid during malaria infections should not
be considered before investigating the effects of uric acid in
different aspects of the disease. Since uric acid has also adjuvant
and anti-oxidant properties, a decrease may exacerbate certain
malaria-associated pathologies.
Materials and Methods
Reagents
All chemical reagents were from Sigma unless otherwise
specified. Uricase (Elitek, Sanofi-Aventis) was further purified
using EndoClean gel filtration columns
TM (BioVintage).
Parasite Culture
Erythrocytic asexual stage cultures of P. falciparum strain 3D7
were maintained in culture medium (RPMI 1640, 25 mM
HEPES, 10 mg/ml gentamycin, 0.5 mM hypoxanthine,
pH 6.75), supplemented with 25 mM sodium bicarbonate and
10% human serum. A 5% hematocrit (O positive, sickle cell
negative, leukocyte depleted erythrocytes) was maintained in the
atmospheric conditions of 1% oxygen, 5% carbon dioxide and
94% nitrogen. The culture medium was changed daily and the
Figure 4. Time course of P. falciparum-induced TNF, IL-6 and IL-1b release from PBMCs in the presence of allopurinol. PBMCs were
incubated with mature P. falciparum infected erythrocytes (squares), uninfected erythrocytes (circles) or media alone (diamonds) at a ratio of (5:1;
erythrocyte:PBMC) for the indicated time points in the presence (white symbols) or absence (black symbols) of 2 mM allopurinol. Incubation media
were collected and TNF (A), IL-6 (B), IL-1b (C) or IL-10 (D) concentrations were determined by ELISA. Data represent the average of triplicated samples
with standard deviations. *, indicates significant differences (p,0.05) in cytokine release by PBMCs incubated with iRBCs when compared to IRBCs in
the presence of allopurinol.
doi:10.1371/journal.pone.0005194.g004
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6%. Parasite cultures were kept synchronized using the gelatin
flotation method [30]. To determine parasitemia, the number of
parasitized erythrocytes from 500 cells in a Giemsa stained this
blood smear were counted. Cultures were routinely shown to be
free of mycoplasma by PCR.
Parasite Growth Curve
To synchronize cultures for growth curve experiments,
trophozoites were selected by gelatin flotation method [30] 24 h
before setting up experiments with ring stage parasites. Triplicate
cultures were seeded at 0.5% ring stage parasites in parasite
culture media in the presence or absence of 2 mM allopurinol.
Cultures were maintained for 48 h without subculturing and the
media was changed daily. Parasitemia was determined daily.
Lysate Preparation
Mature P. falciparum infected erythrocytes were purified by the
gelatin flotation method [30]. As a control, non-parasitzed
erythrocytes were prepared in parallel. 2610
8 infected or
uninfected erythrocytes were subjected to 20 cycles of freeze
thawing. Lysates were then centrifuges at 10,000 g for 10 minutes
and the supernatant was collected and dried for GC-MS analysis.
Quantification of Hypoxanthine by Gas Chromatography
– Single Reaction Monitoring Mass Spectrometry (GC-MS)
The dry sample residues were sonicated in 500 ml of HPLC
grade water (ThermoFisher), centrifuged and the supernatant
removed. Extracts (20% of total) were evaporated to dryness and
derivatized to t-butyldimethylsilyl (TBDMS) derivatives and
analyzed by capillary gas chromatography – ammonia chemical
ionization single reaction monitoring mass spectrometry. 100 mlo f
this extract was mixed with 200 ml of HPLC grade methanol
(ThermoFisher) and the solvent evaporated to dryness under a
stream of nitrogen at 60uC. N-Methyl-N-(tert-butyldimethylsilyl)-
trifluoroacetamide containing 1% tert-butyldimethylchlorosilane
(100 ml, Pierce) was added to each sample. The samples were
heated at 60u for 30 min to form the TBDMS derivatives. This
reaction mixture was analyzed by GC-MS using a Waters
Quattro-II triple quadrupole mass spectrometer equipped with
an Agilent 6890 gas chromatograph. The sample (2 ml) was
injected in the splitless mode onto a 30 m60.25 mm ID MS DB-5
capillary GC column (J&W Scientific; 1 mm phase thickness) with
the injection temperature at 280uC and the column temperature at
210uC. The column temperature was held at 210uC for 1 min,
programmed to 260u at 5u/min and held at 260u for 7 min.
Ammonia chemical ionization was used with the source pressure
at 4e-4 mBar and 175uC. The TBDMS hypoxanthine m/z 365.2
MH
+ ion was isolated and collisionally activated (25 eV, 7e-4
mBar argon) and its m/z 251.2 product ion (loss of TBDMS)
selectively monitored. Peak areas from the selected reaction
monitoring ion plots were compared to those from a 3-point
hypoxanthine calibration curve from 20 to 300 ng to calculate the
amounts of hypoxanthine present in each sample. All analyses
were performed in duplicate.
PBMC Isolation
Leukocyte enriched buffy coats were obtained from the NY
Blood Center (Long Island City, NY) and diluted with equal
volumes of RPMI (Invitrogen). PBMCs were separated by density
gradient centrigugation on 25% Ficoll-Hypaque (GE healthcare).
PBMCs were collected, washed two times with RPMI and
resuspended in RPMI +10% heat inactivated human AB serum
(Valley Biomedicals, Winchester, VA).
PBMC and Parasite co-culture
Mature P. falciparum infected erythrocytes were purified by the
gelatin flotation method [30] and incubated with 1610
6/ml
PBMCs for the indicated time points and ratios at 37uC, 5%CO2.
The incubation media used was RPMI supplemented with 10%
heat inactivated human AB serum, 20 mg/ml gentamicin and
10 mM HEPES. At the indicated time points, incubation media
was harvested, centrifuged to remove cells and cytokine were
measured. Cytokine levels were measured by ELISA (OPTI-EIA
kit, BD Biosciences) or by cytometirc bead array (human
inflammatory cytokine kit, BD Biosciences) when indicated
according to the manufacturers instructions.
Statistical analysis
All data were analysed using GraphPad Prism software.
Significant differences were determined using one-way ANOVA.
Data were considered significant if p,0.05.
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